SCHEMBL4094272

SCHEMBL4094272

CC(C)C(=O)Nc1cccc(N)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MDM4 O15151 2/20 0.53
▸ TP53 P04637 2/20 0.53
▸ CETP P11597 1/20 0.50
▸ LMNA P02545 4/20 0.47
▸ MDM2 Q00987 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ GPR35 Q9HC97 1/20 0.43
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ POLB P06746 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14519906 0.83 MEN1 (0.61) MDM4TP53CETPLMNAMEN1
SCHEMBL6878531 0.82 MDM4 (0.65) MDM4TP53CETPMDM2L3MBTL1
SCHEMBL3118143 0.81 ALDH1A1 (0.48) LMNAHDAC3HDAC1HDAC2GPR35
SCHEMBL16281636 0.79 MDM4 (0.51) MDM4TP53CETPLMNAMDM2
SCHEMBL20761408 0.76 MDM4 (0.77) MDM4TP53CETPLMNAMDM2
SCHEMBL8006420 0.75 MDM4 (0.65) MDM4TP53CETPMDM2L3MBTL1
SCHEMBL11737069 0.74 MDM4 (0.63) MDM4TP53CETPLMNAMDM2
SCHEMBL16330054 0.74 TP53 (0.63) MDM4TP53CETPLMNAMDM2
SCHEMBL10955477 0.74 HTT (0.56) LMNAHDAC3HDAC1HDAC2MEN1
SCHEMBL1750128 0.73 MEN1 (0.58) LMNAMEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 MDM4 3386/4885TP53 2984/4885CETP 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback